# RKDA (Arcadia Biosciences, Inc.) - SEC EDGAR Financial Statements

> Arcadia Biosciences, Inc. reported $5.06M in revenue and a net loss of $10.23M for the trailing twelve months ended September 30, 2026 (up 24.3% year over year), with a 41.1% gross margin and a -68.9% operating margin.

- Canonical: https://convexityos.com/fundamentals/RKDA
- Markdown: https://convexityos.com/fundamentals/RKDA.md
- SEC CIK: 0001469443
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:15 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001469443&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $5.06M | +24.3% YoY |
| Operating Income | TTM | -$3.49M | -68.9% margin |
| Net Income | TTM | -$10.23M | -202.1% net margin |
| Diluted EPS | TTM | -$1.69 | Split-adjusted |
| Free Cash Flow | TTM | -$4.70M | -92.8% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $2.84M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $4.86M | $5.04M | $4.45M | $7.42M | $6.78M | $8.03M | $1.17M | $1.46M | $4.03M | $3.19M |
| Cost of Revenue | $3.10M | $2.96M | $2.17M | $6.10M | $8.71M | $5.20M | -- | -- | $283K | $895K |
| **Gross Profit** | $1.76M | $2.08M | $2.28M | $1.32M | -$1.93M | $2.83M | -- | -- | $3.74M | $2.29M |
| Research & Development | $9.0K | $53K | $64K | $1.51M | $3.89M | $7.96M | $7.10M | $6.07M | $7.41M | $8.66M |
| Selling, General & Admin | $7.00M | $9.64M | $8.23M | $15.04M | $22.94M | $16.47M | $13.57M | $11.60M | $10.65M | $12.25M |
| Total Operating Expenses | -- | -- | -- | -- | -- | $20.81M | $20.55M | $18.33M | $18.34M | $21.81M |
| **Operating Income** | -$2.50M | -$3.65M | -$6.10M | -$14.01M | -$35.53M | -$12.78M | -$19.38M | -$16.87M | -$14.31M | -$18.62M |
| **EBITDA** | -$2.47M | -$3.59M | -$5.99M | -$13.53M | -$34.48M | -$12.12M | -$19.19M | -$16.72M | -$14.04M | -$18.32M |
| Interest Expense | -- | -- | -- | -- | $20K | $47K | $5.0K | -- | $747K | $1.32M |
| Income Before Tax | -$2.33M | -$4.31M | -$5.32M | -$10.81M | -$16.13M | -$6.15M | -$28.87M | -$13.47M | -$15.68M | -$19.60M |
| Income Tax Expense | $8.0K | $8.0K | $8.0K | $14K | $2.0K | -$124K | $2.0K | $10K | $26K | $25K |
| **Net Income** | -$2.34M | -$7.04M | -$13.98M | -$15.38M | -$14.66M | -$4.66M | -$28.80M | -$13.48M | -$15.71M | -$19.62M |
| Basic EPS | -$1.71 | -$5.17 | -$11.29 | -$1,026.00 | -$1,102.40 | -$18.80 | -$181.20 | -$143.20 | -$291.20 | -$7,080.00 |
| **Diluted EPS** | -$1.71 | -$5.17 | -$11.29 | -$1,026.00 | -$1,102.40 | -$18.80 | -$181.20 | -$143.20 | -$291.20 | -$7,080.00 |
| Basic Shares Outstanding | 1.4M | 1.4M | 1.2M | 599.4K | 13.3K | 249.0K | 159.1K | 94.2K | 53.9K | 2.8K |
| Diluted Shares Outstanding | 1.4M | 1.4M | 1.2M | 599.4K | 13.3K | 249.0K | 159.1K | 94.2K | 53.9K | 2.8K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.62M | $1.44M | $1.10M | $901K | $1.30M | $1.46M | $1.20M | $1.22M |
| Cost of Revenue | $760K | $812K | $700K | $709K | $884K | $824K | $682K | $827K |
| **Gross Profit** | $859K | $631K | $400K | $192K | $418K | $631K | $518K | $389K |
| Research & Development | $0 | $0 | -- | $0 | $0 | $9.0K | $0 | $13K |
| Selling, General & Admin | $1.70M | $1.13M | $1.18M | $1.57M | $1.57M | $2.12M | $1.74M | $2.65M |
| **Operating Income** | -$839K | -$496K | -$779K | -$1.38M | -$1.15M | -$501K | $530K | -$2.28M |
| **EBITDA** | -$839K | -$496K | -$771K | -$1.37M | -$1.15M | -$486K | $543K | -$2.31M |
| **Net Income** | $1.75M | -$6.27M | -$4.38M | -$1.34M | $856K | -$4.46M | $2.60M | -$4.06M |
| Basic EPS | $0.29 | -$2.09 | -$2.11 | -- | $0.63 | -$3.26 | $1.90 | -- |
| **Diluted EPS** | $0.29 | -$2.09 | -$2.11 | -- | $0.62 | -$3.26 | $1.90 | -- |
| Basic Shares Outstanding | 6.1M | 3.0M | 2.1M | -- | 1.4M | 1.4M | 1.4M | -- |
| Diluted Shares Outstanding | 6.1M | 3.0M | 2.1M | -- | 1.4M | 1.4M | 1.4M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $259K | $4.24M | $6.52M | $20.64M | $28.68M | $14.04M | $8.42M | $12.00M | $9.12M | $2.01M |
| Short-Term Investments | $4.30M | $0 | $5.12M | $0 | -- | $11.62M | $16.91M | $9.82M | $3.90M | $48.55M |
| **Cash & Short-Term Investments** | $4.56M | $4.24M | $11.64M | $20.64M | $28.68M | $25.67M | $25.33M | $21.82M | $13.02M | $50.56M |
| Accounts Receivable, Net | -- | -- | -- | -- | $1.37M | $1.41M | $602K | $165K | $1.23M | $349K |
| Inventory | $1.21M | $904K | $837K | $2.32M | $4.43M | $3.81M | $1.79M | $181K | $229K | $252K |
| **Total Current Assets** | $6.36M | $9.24M | $14.97M | $25.40M | $35.39M | $31.70M | $28.44M | $22.88M | $15.05M | $52.22M |
| Property, Plant & Equipment, Net | $8.0K | $41K | $70K | $680K | $2.29M | $3.54M | $1.80M | $395K | $299K | $508K |
| Goodwill | -- | -- | -- | -- | -- | $408K | -- | -- | -- | -- |
| Intangible Assets | $39K | $39K | $39K | $40K | $484K | $370K | -- | -- | -- | -- |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | $2.50M |
| Other Non-Current Assets | $143K | $92K | $164K | $165K | $180K | $23K | $8.0K | $7.0K | $56K | $19K |
| **Total Non-Current Assets** | $190K | $4.28M | $4.73M | $3.52M | $8.53M | $15.65M | $4.13M | $1.15M | $1.52M | $4.35M |
| **Total Assets** | $6.55M | $13.52M | $19.70M | $28.92M | $43.92M | $47.35M | $32.57M | $24.02M | $16.57M | $56.57M |
| Accounts Payable | $1.45M | $703K | $485K | $905K | $1.41M | $726K | $492K | $285K | $366K | $222K |
| Short-Term Debt | -- | -- | -- | -- | $0 | $1.14M | $24K | -- | -- | $0 |
| Deferred Revenue (Current) | -- | -- | -- | -- | -- | $8.0K | $42K | $96K | $1.00M | $740K |
| Other Current Liabilities | -- | -- | -- | $270K | $264K | $263K | $306K | $284K | -- | -- |
| **Total Current Liabilities** | $2.06M | $2.56M | $3.59M | $4.21M | $5.04M | $6.31M | $5.71M | $3.05M | $3.52M | $3.13M |
| Long-Term Debt | -- | -- | -- | -- | $0 | $2.10M | $107K | $0 | $0 | $25.13M |
| Deferred Revenue (Non-Current) | -- | -- | -- | -- | -- | -- | -- | -- | $2.04M | $3.12M |
| Other Non-Current Liabilities | $0 | $2.00M | $2.00M | $2.00M | $2.07M | $2.28M | $2.00M | $3.07M | $3.00M | $3.00M |
| **Total Non-Current Liabilities** | $347K | $4.73M | $3.41M | $3.81M | $7.68M | $12.48M | $18.54M | $8.15M | $5.04M | $31.25M |
| **Total Liabilities** | $2.41M | $7.29M | $7.00M | $8.02M | $12.72M | $18.80M | $24.25M | $11.21M | $8.56M | $34.38M |
| **Total Debt (incl. Leases)** | -- | $155K | $1.01M | $2.02M | $3.29M | $9.35M | $2.24M | $0 | $0 | $25.13M |
| Common Stock | $65K | $65K | $65K | $65K | $63K | $54K | $49K | $45K | $42K | $44K |
| Retained Earnings | -$281.2M | -$278.9M | -$271.8M | -$257.9M | -$226.5M | -$211.8M | -$207.2M | -$178.4M | -$167.3M | -$151.6M |
| Accumulated Other Comp. Income | -- | $0 | $101K | $0 | -- | -- | $1.0K | -- | -$1.0K | -$19K |
| **Total Stockholders' Equity** | -- | $6.22M | $12.84M | $21.03M | $31.09M | $27.73M | $7.71M | $12.81M | $8.01M | $22.20M |
| Total Equity | $4.14M | $6.22M | $12.70M | $20.90M | $31.20M | $28.55M | $8.32M | $12.81M | $8.01M | $22.20M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $2.84M | $4.18M | $954K | $259K | $1.12M | $1.38M | $3.16M | $4.24M |
| Short-Term Investments | $0 | $0 | $2.77M | $4.30M | $4.76M | $3.07M | -- | $0 |
| **Cash & Short-Term Investments** | $2.84M | $4.18M | $3.72M | $4.56M | $5.88M | $4.44M | $3.16M | $4.24M |
| Inventory | $973K | $930K | $840K | $1.21M | $1.46M | $1.49M | $1.28M | $904K |
| **Total Current Assets** | $4.56M | $5.74M | $5.17M | $6.36M | $8.39M | $7.58M | $8.85M | $9.24M |
| Property, Plant & Equipment, Net | $0 | $0 | $0 | $8.0K | $10K | $12K | $28K | $41K |
| Intangible Assets | $39K | $39K | $39K | $39K | $39K | $39K | $39K | $39K |
| Other Non-Current Assets | $115K | $115K | $115K | $143K | $148K | $148K | $92K | $92K |
| **Total Non-Current Assets** | $154K | $154K | $154K | $190K | $197K | $209K | $4.14M | $4.28M |
| **Total Assets** | $4.72M | $5.89M | $5.32M | $6.55M | $8.58M | $7.79M | $12.99M | $13.52M |
| Accounts Payable | -- | -- | -- | $1.45M | -- | -- | -- | $703K |
| **Total Current Liabilities** | $1.27M | $1.65M | $1.36M | $2.06M | $2.29M | $1.84M | $2.22M | $2.56M |
| Other Non-Current Liabilities | -- | -- | -- | $0 | $0 | $0 | $1.00M | $2.00M |
| **Total Non-Current Liabilities** | $1.04M | $3.61M | $1.07M | $347K | $856K | $1.42M | $1.87M | $4.73M |
| **Total Liabilities** | $2.31M | $5.26M | $2.44M | $2.41M | $3.14M | $3.25M | $4.08M | $7.29M |
| **Total Debt (incl. Leases)** | -- | -- | -- | -- | -- | $11K | $21K | $155K |
| Common Stock | $67K | $66K | $66K | $65K | $65K | $65K | $65K | $65K |
| Retained Earnings | -$290.1M | -$291.9M | -$285.6M | -$281.2M | -$279.9M | -$280.7M | -$276.3M | -$278.9M |
| Accumulated Other Comp. Income | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Stockholders' Equity** | -- | -- | -- | -- | -- | -- | -- | $6.22M |
| Total Equity | $2.40M | $633K | $2.88M | $4.14M | $5.44M | $4.53M | $8.90M | $6.22M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.30M | -$7.04M | -$13.99M | -$15.61M | -$16.13M | -$6.03M | -$28.87M | -$13.48M | -$15.71M | -$19.62M |
| Depreciation & Amortization | $32K | $58K | $111K | $479K | $1.04M | $662K | $194K | $154K | $279K | $304K |
| Stock-Based Compensation | $234K | $512K | $717K | $1.11M | $1.54M | $2.04M | $2.29M | $1.55M | $1.47M | $1.06M |
| Change in Receivables | $165K | -$762K | $184K | $592K | -$40K | -$1.12M | -$437K | $1.07M | -$882K | $357K |
| Change in Inventory | -$308K | $550K | -$2.42M | $1.12M | -$2.38M | -$9.75M | -$1.53M | $160K | $183K | $582K |
| **Operating Cash Flow** | -$4.70M | -$9.63M | -$15.29M | -$13.98M | -$25.87M | -$30.22M | -$17.20M | -$13.63M | -$13.96M | -$17.05M |
| Capital Expenditure | $0 | -$16K | -$5.0K | -$72K | -$1.01M | -$2.33M | -$1.48M | -$250K | -$79K | -$231K |
| **Free Cash Flow** | -$4.70M | -$9.64M | -$15.30M | -$14.05M | -$26.88M | -$32.55M | -$18.68M | -$13.88M | -$14.04M | -$17.29M |
| Acquisitions, Net | -- | -- | -- | $0 | -$4.25M | -$500K | -- | -- | -- | -- |
| Purchases of Investments | -- | $0 | -$7.53M | $0 | -- | -$1.29M | -$28.36M | -$29.89M | -$19.41M | -$41.38M |
| Sales & Maturities of Investments | -- | -- | -- | $0 | $21.85M | $18.25M | $21.45M | $24.15M | $66.66M | $36.31M |
| **Investing Cash Flow** | $750K | $7.34M | -$4.34M | $1.42M | $16.61M | $17.28M | -$8.37M | -$5.97M | $47.18M | -$5.30M |
| **Financing Cash Flow** | $6.0K | $9.0K | $5.51M | $4.52M | $21.90M | $20.56M | $21.99M | $22.48M | -$26.10M | $396K |
| **Net Change in Cash** | -$3.98M | -$2.28M | -$14.13M | -$8.04M | $12.64M | $7.63M | -$3.58M | $2.87M | $7.11M | -$21.96M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | $1.75M | -$6.27M | -$4.38M | -$1.30M | $856K | -$4.46M | $2.60M | -$4.06M |
| Depreciation & Amortization | $0 | $0 | $8.0K | $2.0K | $2.0K | $15K | $13K | -$34K |
| Stock-Based Compensation | $14K | $14K | $15K | $17K | $53K | $86K | $78K | $117K |
| Change in Receivables | -$66K | -$134K | $0 | $406K | $176K | -$224K | -$193K | -$317K |
| Change in Inventory | -$43K | -$90K | $372K | $244K | $33K | -$204K | -$381K | -$70K |
| **Operating Cash Flow** | -$1.28M | -$319K | -$1.10M | -$822K | -$257K | -$2.03M | -$1.59M | -$2.21M |
| Capital Expenditure | -- | -- | -- | $0 | $0 | $0 | $0 | $0 |
| **Free Cash Flow** | -- | -- | -- | -$822K | -$257K | -$2.03M | -$1.59M | -$2.21M |
| **Investing Cash Flow** | $0 | $0 | $0 | $0 | $0 | $250K | $500K | $2.52M |
| **Financing Cash Flow** | -$55K | $3.54M | $1.79M | $0 | $1.0K | $0 | $5.0K | $0 |
| **Net Change in Cash** | -$1.33M | $3.22M | $695K | -$861K | -$256K | -$1.78M | -$1.08M | $306K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 36.2% | 41.3% | 51.2% | 17.8% | -28.4% | 35.3% | -- | -- | 93.0% | 71.9% |
| **Operating Margin** | -51.5% | -72.3% | -137.0% | -188.8% | -524.0% | -159.0% | -1657.9% | -1152.3% | -355.6% | -584.1% |
| **Net Profit Margin** | -48.1% | -139.5% | -313.9% | -207.3% | -216.2% | -57.9% | -2464.1% | -920.8% | -390.1% | -615.6% |
| Return on Equity (ROE) | -- | -113.1% | -108.9% | -73.1% | -47.1% | -16.8% | -373.8% | -105.2% | -196.2% | -88.4% |
| Return on Assets (ROA) | -35.7% | -52.1% | -71.0% | -53.2% | -33.4% | -9.8% | -88.4% | -56.1% | -94.8% | -34.7% |
| Current Ratio | 3.09x | 3.61x | 4.17x | 6.03x | 7.02x | 5.02x | 4.98x | 7.49x | 4.27x | 16.69x |
| Quick Ratio | 2.50x | 3.25x | 3.94x | 5.48x | 6.14x | 4.42x | 4.67x | 7.43x | 4.20x | 16.61x |
| Debt to Equity | -- | 0.02x | 0.08x | 0.10x | 0.11x | 0.34x | 0.29x | 0.00x | 0.00x | 1.13x |
| **Revenue Growth (YoY)** | -3.7% | +13.3% | -40.0% | +9.4% | -15.6% | +587.3% | -20.2% | -63.6% | +26.3% | -41.1% |
| Gross Profit Growth (YoY) | -15.5% | -8.7% | +73.1% | -- | -168.0% | -- | -- | -- | +63.2% | -49.3% |
| 5Y Revenue / Share Growth | -89.0% | -49.6% | -76.8% | -83.4% | -55.7% | -78.7% | -99.7% | -- | -- | -- |
| 10Y Revenue / Share Growth | -97.7% | -99.9% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 41.1% | 34.6% | 34.5% | 36.2% | 37.8% | 37.8% | 39.6% | 41.3% |
| **Operating Margin** | -68.9% | -80.1% | -80.0% | -51.4% | -65.8% | -74.1% | -29.1% | -72.3% |
| **Net Profit Margin** | -202.1% | -234.5% | -195.9% | -48.1% | -98.0% | -139.3% | -38.3% | -139.5% |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -- | -113.1% |
| Return on Assets (ROA) | -217.0% | -188.9% | -175.1% | -35.7% | -59.0% | -96.8% | -15.5% | -52.1% |
| Current Ratio | 3.58x | 3.49x | 3.79x | 3.09x | 3.67x | 4.12x | 3.99x | 3.61x |
| Quick Ratio | 2.82x | 2.92x | 3.17x | 2.50x | 3.03x | 3.31x | 3.41x | 3.25x |
| Debt to Equity | -- | -- | -- | -- | -- | -- | -- | 0.02x |
| **Revenue Growth (YoY)** | +24.3% | -0.8% | -8.3% | -25.9% | -15.3% | +11.4% | +21.6% | +56.5% |
| Gross Profit Growth (YoY) | +105.5% | 0.0% | -22.8% | -50.6% | -17.2% | -6.2% | +0.4% | -35.1% |
| Operating Income Growth (YoY) | -- | -- | -247.0% | -- | -- | -125.3% | -- | -- |
| **Net Income Growth (YoY)** | +105.0% | -- | -268.7% | -- | -- | -520.2% | -- | -- |
| EPS Growth (YoY) | -54.0% | -- | -211.1% | -- | -- | -517.9% | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
